Supriya Lifescience standalone net profit rises 47.34% in the March 2026 quarter

Sales rise 50.20% to Rs 276.53 crore

Net profit of Supriya Lifescience rose 47.34% to Rs 74.23 crore in the quarter ended March 2026 as against Rs 50.38 crore during the previous quarter ended March 2025. Sales rose 50.20% to Rs 276.53 crore in the quarter ended March 2026 as against Rs 184.11 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.26% to Rs 209.12 crore in the year ended March 2026 as against Rs 187.96 crore during the previous year ended March 2025. Sales rose 18.86% to Rs 827.88 crore in the year ended March 2026 as against Rs 696.49 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	276.53	184.11	50	827.88	696.49	19
OPM %	35.30	36.71	-	35.52	37.44	-
PBDT	100.63	70.14	43	303.65	268.93	13
PBT	92.13	64.06	44	275.24	248.49	11
NP	74.23	50.38	47	209.12	187.96	11

Powered by Capital Market - Live News